As autoimmunity may reflect antitumor immunity, the primary objective of the current study was to investigate whether SNPs in genes related to the PD-1 axis and involved in autoimmunity are predictive for OS in patients with metastatic melanoma and anti-PD-1 monotherapy. The gene discussed is PDCD1; the disease is Autoimmunity.